Published in Clin Interv Aging on January 01, 2006
Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One (2012) 1.76
Systematic review on the efficacy and safety of herbal medicines for vascular dementia. Evid Based Complement Alternat Med (2011) 0.82
Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment. Neuropsychiatr Dis Treat (2014) 0.82
Role of EEG as biomarker in the early detection and classification of dementia. ScientificWorldJournal (2014) 0.81
Cognitive assessments for the early diagnosis of dementia after stroke. Neuropsychiatr Dis Treat (2014) 0.77
Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia. Neural Regen Res (2013) 0.77
miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications. Front Cell Neurosci (2016) 0.75
The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat Med (2016) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology (1994) 21.65
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet (2001) 17.97
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61
Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke (1996) 7.81
Statins and the risk of dementia. Lancet (2000) 5.65
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet (2002) 5.05
MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) (1985) 4.98
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol (1991) 3.70
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol (2001) 3.43
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology (1995) 2.69
Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities. J Neurol Neurosurg Psychiatry (1994) 2.40
Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol (2005) 2.39
Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke (2003) 2.19
Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol (2002) 2.18
Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology (2001) 2.18
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol (2004) 2.09
Incidence of dementia: does gender make a difference? Neurobiol Aging (2001) 1.81
Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev (2004) 1.69
Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci (2004) 1.60
Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke (1997) 1.56
Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol (1993) 1.54
Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology (2003) 1.53
Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet (1993) 1.49
Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study. Neurology (1999) 1.44
Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc (1998) 1.35
Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry (1999) 1.35
Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging (2001) 1.34
A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol (2002) 1.29
Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology (1998) 1.26
Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol (2001) 1.24
Leukoaraiosis: an independent risk factor for stroke? Stroke (2003) 1.21
Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study. Stroke (1994) 1.19
Frequency and clinical determinants of dementia after ischemic stroke. Neurology (2000) 1.19
Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias. Eur Arch Psychiatry Clin Neurosci (1991) 1.19
Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke (1992) 1.15
A quantitative MRI study of vascular dementia. Neurology (1992) 1.08
A 2-year follow-up study of cigarette smoking and risk of dementia. Eur J Neurol (2004) 1.07
Prevalence and etiology of dementia in a Japanese community. Stroke (1992) 1.06
Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc (2002) 1.03
Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord (2000) 1.02
Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study. Arzneimittelforschung (1992) 1.01
A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology (2003) 1.01
Coronary artery bypass grafting (CABG) and cognitive decline: a review. J Neurol Sci (2004) 1.00
Significant progression of white matter lesions and small deep (lacunar) infarcts in patients with stroke. Arch Neurol (1996) 0.96
Epidemiology of vascular dementia. Neuroepidemiology (1995) 0.92
The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord (2000) 0.88
How does cerebrovascular disease cause dementia? Dementia (1994) 0.86
Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. Toxicology (2000) 0.85
Lessons from mixed dementia. Int Psychogeriatr (1997) 0.84
Clinical trials in dementia with propentofylline. Ann N Y Acad Sci (1997) 0.84
New approaches to clinical trials in vascular dementia: memantine in small vessel disease. Cerebrovasc Dis (2002) 0.83
The neurochemistry of vascular dementia. Dementia (1994) 0.82
Vascular dementia: diagnosis, management and possible prevention. Med J Aust (1999) 0.82
Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials. Alzheimer Dis Assoc Disord (1998) 0.82
[Prevalence study on dementia and Alzheimer disease]. Zhonghua Yi Xue Za Zhi (1990) 0.80
Perspectives in the treatment of vascular dementia. Drugs Today (Barc) (2000) 0.80
The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia. J Neurol Sci (2000) 0.79
Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen (2003) 0.79
Prevention of dementia: Syst-Eur trial. Lancet (1999) 0.78
Hereditary vascular dementia linked to notch 3 mutations. CADASIL in British families. Ann N Y Acad Sci (2000) 0.78
Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med (2012) 5.64
Statins for the prevention of dementia. Cochrane Database Syst Rev (2009) 2.38
A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease. Int J Geriatr Psychiatry (2004) 2.21
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev (2009) 1.56
Statins for the prevention of dementia. Cochrane Database Syst Rev (2016) 1.43
Can we afford not to have integrated dementia services? Age Ageing (2007) 1.38
Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry (2010) 1.26
Statins for the treatment of dementia. Cochrane Database Syst Rev (2010) 1.23
Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease. PLoS One (2010) 1.07
Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study. Mol Neurodegener (2011) 1.01
The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practice. Pharmacoepidemiol Drug Saf (2002) 0.93
Statins for the treatment of dementia. Cochrane Database Syst Rev (2014) 0.92
Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS). Neurobiol Aging (2012) 0.92
A multi-center study of ACE and the risk of late-onset Alzheimer's disease. J Alzheimers Dis (2011) 0.89
AD2000: design and conclusions. Lancet (2004) 0.87
Cochrane review on 'Statins for the treatment of dementia'. Int J Geriatr Psychiatry (2012) 0.86
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. Trials (2009) 0.86
TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease. Neurobiol Aging (2007) 0.84
Can statins prevent or help treat Alzheimer's disease? J Alzheimers Dis (2010) 0.83
A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease. Pharmacogenet Genomics (2006) 0.83
Assessment of factors that influence physician decision making regarding medication use in patients with dementia at the end of life. Int J Geriatr Psychiatry (2013) 0.79
Development and application of medication appropriateness indicators for persons with advanced dementia: a feasibility study. Drugs Aging (2015) 0.77
Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2007) 0.76
Development of a cell phone-based video streaming system for persons with early stage Alzheimer's disease. Conf Proc IEEE Eng Med Biol Soc (2008) 0.75
Next generation sequencing of CLU, PICALM and CR1: pitfalls and potential solutions. Int J Mol Epidemiol Genet (2012) 0.75
Pain assessment in cognitive impairment. J Pain Palliat Care Pharmacother (2014) 0.75
Visualization and Post-processing of 5D Brain Images. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
Introduction to genetic epidemiology. Optometry (2010) 0.75